Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

627 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population.
Nakamura N, Kanemura N, Matsumoto T, Nakamura H, Ikoma Y, Shibata Y, Kitagawa J, Kasahara S, Yamada T, Sawada M, Kaneda Y, Fukuno K, Takada E, Goto H, Lee S, Fujita K, Morishita T, Hara T, Tsurumi H, Shimizu M. Nakamura N, et al. Among authors: kasahara s. Sci Rep. 2023 Nov 4;13(1):19060. doi: 10.1038/s41598-023-46501-5. Sci Rep. 2023. PMID: 37925551 Free PMC article.
A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma.
Nakamura N, Kasahara S, Kitagawa J, Nakamura H, Sawada M, Fukuno K, Shibata Y, Kaneda Y, Hara T, Kanemura N, Tsurumi H, Shimizu M. Nakamura N, et al. Among authors: kasahara s. Exp Hematol Oncol. 2022 Feb 25;11(1):9. doi: 10.1186/s40164-022-00264-3. Exp Hematol Oncol. 2022. PMID: 35216626 Free PMC article.
A phase II study of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed or refractory non-Hodgkin lymphoma.
Ikoma Y, Nakamura N, Kitagawa J, Miwa T, Takada E, Matsumoto T, Shibata Y, Nakamura H, Kanemura N, Kasahara S, Hara T, Sawada M, Tsurumi H, Shimizu M. Ikoma Y, et al. Among authors: kasahara s. Hematol Oncol. 2024 Jan;42(1):e3236. doi: 10.1002/hon.3236. Epub 2023 Nov 6. Hematol Oncol. 2024. PMID: 37932900 Clinical Trial.
The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma.
Kaneda Y, Kanemura N, Nakamura N, Ikoma Y, Yamaguchi K, Takada E, Shibata Y, Lee S, Fujita K, Morishita T, Matsumoto T, Nakamura H, Kitagawa J, Kasahara S, Hara T, Tsurumi H, Shimizu M. Kaneda Y, et al. Among authors: kasahara s. Leuk Lymphoma. 2024 Mar;65(3):339-345. doi: 10.1080/10428194.2023.2295787. Epub 2023 Dec 20. Leuk Lymphoma. 2024. PMID: 38124378
Clinical significance of jejunoileal involvement of non-Hodgkin's lymphoma detected by double-balloon enteroscopy.
Ibuka T, Tsurumi H, Araki H, Hara T, Onogi F, Goto N, Kojima Y, Kanemura N, Shiraki M, Kasahara S, Shimizu M, Ogawa K, Ninomiya S, Nakanishi T, Kato T, Takami T, Moriwaki H. Ibuka T, et al. Among authors: kasahara s. Int J Hematol. 2013 Mar;97(3):369-81. doi: 10.1007/s12185-013-1273-4. Epub 2013 Feb 2. Int J Hematol. 2013. PMID: 23378170 Free article. Clinical Trial.
627 results